DuPont Extends $6.1 Billion Danisco Bid to April 1

U.S. chemicals group DuPont extended its 33.4 billion crown ($6.1 billion) offer for Danish food and enzymes group Danisco to April 1, hoping to gain more acceptances as regulators clear the deal.

The 665-crowns-per-share offer announced Jan. 9 was set to expire next Tuesday, with DuPont saying it required acceptances from shareholders with at least 90 percent of the stock to carry out the deal.

DuPont said on Friday only 5% of shareholders had accepted, adding most do not do so until all regulatory approvals are obtained. Some approvals are still pending.

However, financial analysis firm Aktieinfo's chief analyst Lau Svenssen said the 5% acceptance did not bode well.

"It does not indicate small problems, but big problems," Svenssen said, adding he expected DuPont to raise its bid -- something the U.S. company has repeatedly said it will not do.

Competition approval has been obtained in the U.S., and DuPont said it expected approvals in China and the EU.

If all competition approvals have not been obtained by April 1, the offer will be extended to April 29, DuPont said, adding it still expected to complete the deal in the second quarter.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.